CVS Health elects Jeffrey R. Balser, MD, PhD to Board of Directors

CVS HEALTH Corp

Dr. Balser has served as President and CEO of Vanderbilt University Medical Center since 2009.
He guided VUMC's $1.2 billion public debt issuance and legal separation from Vanderbilt University.
Balser was appointed to the Board's Medical Affairs Committee and deemed independent under NYSE rules.
His compensation matches other non-employee directors, prorated from September 12, 2022.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jeffrey R. Balser

Director

CVS · CVS HEALTH Corp

Effective: 2022-09-12
Filed: September 13, 2022, 7:59 PM ET

Effective September 12, 2022, the Board of Directors (the “Board”) of CVS Health Corporation (“CVS Health” or the “Company”) elected Jeffrey R. Balser, M.D., Ph.D., to serve on the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jeffrey R. Balser was elected as Director at CVS HEALTH Corp.

Action: elected
Role: Director

Exact text from the filing

Effective September 12, 2022, the Board of Directors (the “Board”) of CVS Health Corporation (“CVS Health” or the “Company”) elected Jeffrey R. Balser, M.D., Ph.D., to serve on the Board.

View on SEC.gov

CVS HEALTH Corp filing history →

Source: SEC EDGAR

accession 0000947871-22-000962

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.